Influence of impactor operating flow rate on particle size distribution of four jet nebulizers

Pharmaceutical Development and Technology

Volumn 12, Issue 4, 2007, Pages 353-359

  Zhou, Yue ^a,d   Brasel, Trevor L ^a   Kracko, Dean ^a   Cheng, Yung Sung ^a   Ahuja, Amitkumar ^b   Norenberg, Jeffrey P ^c   Kelly, H William ^c  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d NONE   (United States)

Author keywords

Flow rate; Impactor; Nebulizer

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; SALBUTAMOL;

ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FLOW RATE; GEOMETRY; HUMIDITY; NEBULIZATION; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; BUDESONIDE; CHEMISTRY, PHARMACEUTICAL; EQUIPMENT DESIGN; HUMIDITY; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 34548363463     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701366937     Document Type: Article

References (16)

1. Stapleton, K.W.; Finlay, W.H. Errors in characterizing nebulized particle size distributions with cascade impactors. J. Aerosol Med. 1998, 11 (S1), 80-83.
2. Zhou, Y.; Ahuja, A.; Irvin, C.M.; Kracko, D.; McDonald, J.D.; Cheng, Y.S. Evaluation of nebulizer performance under various humidity conditions. J. Aerosol Med. 2005a, 18, 283-293.
3. Zhou, Y.; Ahuja, A.; Irvin, C.M.; Kracko, D.; McDonald, J.D.; Cheng, Y.S. Medical nebulizer performance: Effects of cascade impactor temperature. Respir. Care 2005b, 50, 1077-1082.
4. ICRP (International Commission on Radiological Protection). Human Respiratory Tract Model for Radiological Protection. In Annals of the ICRP. Pergamon Press: Oxford, 1994; publication 66, p 24.
5. Cheng, Y.S.; Fu, C.; Yazzie, D.; Zhou, Y. Respiratory deposition patterns of salbutamol PMDI with CFC and HFA-134a formulations in a human airway replica. J. Aerosol. Med 2001, 14, 255-266.
6. Clark, A.R.; Newman, S.P.; Dasovich, N. Mouth and oropharyngeal deposition of pharmaceutical aerosols. J. Aerosol Med. 1998, 11, S116-121.
7. Dolovich, M.A. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir. Care 2000, 45, 597-608.
8. Pitcairn, G.; Lunghetti, G.; Ventura, P.; Newman, S. A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler at two inhaled flow rates. Int. J. Pharma. 1994, 102, 11-18.
9. Loffert, D.T.; Ikle, D.; Nelson, H.S. A comparison of commercial jet nebulizers. Chest 1994 106, 1788-1793.
10. Newnham, D.M.; Lipworth, B.J. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax 1994, 49, 762-770.
11. Rader, D.J.; Marple; V.A. Effect of Ultra-Stokesian drug and particle interception on impaction characteristics. Aerosol Sci. Technol. 1985, 4, 141-156.
12. Chen, B.T.; Cheng, Y.S.; Yeh, H.C. Experimental responses of two optical particle counters. J. Aerosol Sci. 1984, 15, 457-464.
13. Cheng, Y.S.; Yazzie, D.; Gao, J.; Muggli, D.; Etter, J.; Rosner, D.E. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology. J. Aerosol Med. 2003, 16, 65-73.
14. Mitchell, J.P.; Costa, P.A.; Waters, S. An assessment of an Andersen Mark-II cascade impactor. J. Aerosol Sci. 1988, 19, 213-221.
15. Dennis, J.; Ameen, F. Cascade impaction of nebulized aerosol. Drug Delivery to the Lungs Conference XIV, London, 2003.
16. Ho, S.L.; Kwong, W.T.J.; O'Drowsky, L.; Coates, A.L. Evaluation of four breath-enhanced nebulizers for home use. J. Aerosol Med. 2001, 14, 467-475.